Pharmacogenomics: Bridging the Gap Between Genetics and Drug Response

Clicks: 95
ID: 287774
2024
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal
Popular

Ranked #1 of 8 articles by views in The Physicians' Review

Most read Least read

Bar heights use a square-root scale.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Pharmacogenomics, the study of how genetic variations influence drug response, is revolutionizing personalized medicine. By integrating genetic information into clinical practice, healthcare providers can optimize drug efficacy and minimize adverse effects. This article explores the current landscape of pharmacogenomics, highlighting its applications, challenges, and future directions. Emphasis is placed on the role of pharmacogenomic testing in tailoring drug therapies to individual genetic profiles, thereby enhancing patient outcomes.
Reference Key
Johnson2024thePharmacogenomics: Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Dr. Emily Johnson;
Journal The Physicians' Review
Year 2024
DOI
8
URL
https://tprjournal.com/index.php/tpr/article/view/8
Keywords
pharmacogenomics drug response genetic variations personalized medicine drug efficacy

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.